New drugs. Topoisomerase inhibitors
Gutzler, F.
Zentralblatt für Gynakologie 118(10): 579
1996
ISSN/ISBN: 0044-4197 PMID: 8999716 Document Number: 468260
Document emailed within 1 workday
Related Documents
Meikle, I.; Cummings, J.; Macpherson, J.S.; Smyth, J.F. 1995: Identification of anthracenyl-dipeptide conjugates as novel topoisomerase i and Ii inhibitors and their evaluation as potential anticancer drugs Anti-Cancer Drug Design 10(7): 515-527Giaccone, G. 1994: DNA topoisomerases and topoisomerase inhibitors Pathologie-Biologie 42(4): 346-352
Verschraegen, C.F.; Kudelka, A.P.; Kavanagh, J.J. 1998: Topoisomerase-i inhibitors in gynaecologic tumours Annals of the Academy of Medicine Singapore 27(5): 683-687
Alpan, A.Selcen.; Gunes, H.Semih.; Topcu, Z. 2007: 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors Acta Biochimica Polonica 54(3): 561-565
Rothenberg, M.L.; Blanke, C.D. 1999: Topoisomerase i inhibitors in the treatment of colorectal cancer Seminars in Oncology 26(6): 632-639
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Fukuoka, M. 2001: Role of topoisomerase i inhibitors in small-cell lung cancer Oncology 15(7 Suppl 8: 9-13
Cho, L.C.; Choy, H. 2004: Topoisomerase i inhibitors in the combined-modality therapy of lung cancer Oncology 18(7 Suppl 4: 29-39
Wang, W.; Tse-Dinh, Y-Ching. 2019: Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy Current Topics in Medicinal Chemistry 19(9): 730-740
Chavalitshewinkoon-Petmitr, P.; Worasing, R.; Wilairat, P. 2001: Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors Southeast Asian Journal of Tropical Medicine and Public Health 32(4): 733-738
Arakawa, Y. 2015: DNA topoisomerase I--targeting drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 174-177
Szmigiero, L. 1988: Topoisomerase Ii as a cellular receptor of various antineoplastic drugs Postepy Biochemii 34(3): 147-152
Robson, C.N.; Hoban, P.R.; Harris, A.L.; Hickson, I.D. 1987: Cross-sensitivity to topoisomerase Ii inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines Cancer Research 47(6): 1560-1565
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Meliksetian, M.B.; Berezkina, E.V.; Pavlenko, M.A.; Grinchuk, T.M. 1999: Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase Ii inhibitors adriamycin and etoposide Tsitologiia 41(7): 615-621
Coleman, L.W.; Bronstein, I.B.; Holden, J.A. 2001: Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas Anticancer Research 21(2a): 1167-1172
Bonnici, F.; Omar, M.A. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors have a more beneficial effect on biochemical parameters than low-dose thiazides South African Medical Journal 80(5): Suppl 6
Herzog, C.E.; Holmes, K.A.; Tuschong, L.M.; Ganapathi, R.; Zwelling, L.A. 1998: Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha Cancer Research 58(23): 5298-5300
Ishida, R.; Miki, T.; Narita, T.; Yui, R.; Sato, M.; Utsumi, K.R.; Tanabe, K.; Andoh, T. 1991: Inhibition of intracellular topoisomerase Ii by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors Cancer Research 51(18): 4909-4916
de Tinguy-Moreaud, E.; Pourquier, P.; Montaudon, D.; Robert, J. 1994: Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells Anticancer Research 14(1a): 99-103